MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX)

Q2 2022 13F Holders as of 6/30/2022

Type / Class: Equity / Common Stock, par value $0.01 per share
Shares outstanding: 62M
Number of holders: 118
Total 13F shares, excl. options: 56.8M
Shares change: +1.32M
Total reported value, excl. options: $168M
Value change: -$40M
Number of buys: 68
Number of sells: -61
Price: $2.95

Significant Holders of MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX) as of Q2 2022

150 filings reported holding MGNX - MACROGENICS INC - Common Stock, par value $0.01 per share as of Q2 2022.
MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 56.8M shares of 62M outstanding shares and own 91.61% of the company stock.
Largest 10 shareholders include Bellevue Group AG (7.33M shares), ARMISTICE CAPITAL, LLC (6.13M shares), WASATCH ADVISORS INC (4.39M shares), RTW INVESTMENTS, LP (3.98M shares), VANGUARD GROUP INC (3.93M shares), MILLENNIUM MANAGEMENT LLC (2.61M shares), Assenagon Asset Management S.A. (1.8M shares), RENAISSANCE TECHNOLOGIES LLC (1.43M shares), STATE STREET CORP (1.27M shares), and PERCEPTIVE ADVISORS LLC (1.23M shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.